Tomoyuki Yoshikawa

Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients

Tadashi Aoyama, Masashi Takano, Morikazu Miyamoto et al. · Oncology · 2019 · 79 citations

Clear Cell Adenocarcinoma Associated With Clear Cell Adenofibromatous Components: A Subgroup of Ovarian Clear Cell Adenocarcinoma With Distinct Clinicopathologic Characteristics

Sohei Yamamoto, Hitoshi Tsuda, Tomoyuki Yoshikawa et al. · The American Journal of Surgical Pathology · 2007 · 61 citations

Ccaf Components, Tumoral Pathology, Medicine +10

Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers

Masashi Takano, Masafumi Kato, Tomoyuki Yoshikawa et al. · Oncology · 2009 · 59 citations

JAK2/STAT3 pathway as a therapeutic target in ovarian cancers

Tomoyuki Yoshikawa, Morikazu Miyamoto, Tadashi Aoyama et al. · Oncology Letters · 2018 · 54 citations · Full text

Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers

Tomoyuki Yoshikawa, Masashi Takano, Morikazu Miyamoto et al. · Cancer Chemotherapy and Pharmacology · 2017 · 40 citations

Psoas Muscle Volume, Oncology, Tumor Innervation +9